Clinical Trials

Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)

Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia

Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study

Impact of the Preparation Method of Red Cell Concentrates on Transfusion Indices in Thalassemic Patients

Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major

Pharmacokinetics of Oral Hydroxyurea Solution

Quantitative Susceptibility Mapping (QSM) to Guide Iron Chelating Therapy

Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload

The Use of CGMS to Detect Alterations of Blood Glucose in Thalassemic Patients

Trial of HQK-1001 in Beta Thalassemia Intermedia in Lebanon

Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia

Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients

Thyroid Function , HbA1c in Relation to Ferritin Level in Adullt Patient e B Thalassemia

A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia

Adherence of Beta Thalssemia Patients to Oral Chelation Therapy

Atrial Fibrillation in Beta-Thalassemia

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies

RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)